CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial
- 11 August 2006
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 368 (9534), 459-465
- https://doi.org/10.1016/s0140-6736(06)69153-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Impact of Therapeutic Immunization on HIV‐1 Viremia after Discontinuation of Antiretroviral Therapy Initiated during Acute InfectionThe Journal of Infectious Diseases, 2005
- Development of HIV with Drug Resistance after CD4 Cell Count--Guided Structured Treatment Interruptions in Patients Treated with Highly Active Antiretroviral Therapy after Dual--Nucleoside Analogue TreatmentClinical Infectious Diseases, 2005
- Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected SubjectsAIDS Research and Human Retroviruses, 2004
- Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialAIDS, 2003
- A Prospective Trial of Structured Treatment Interruptions in Human Immunodeficiency Virus InfectionArchives of Internal Medicine, 2003
- Can Structured Treatment Interruptions (STIs) Be Used as a Strategy to Decrease Total Drug Requirements and Toxicity in HIV Infection?Journal of the International Association of Physicians in AIDS Care, 2002
- Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidenceThe Lancet, 2002
- Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort StudyThe Lancet, 2001
- Estimating the National Cost of Treating People With HIV Disease: Patient, Payer, and Provider DataJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- AIDS-Related Opportunistic Illnesses Occurring After Initiation of Potent Antiretroviral TherapyJama-Journal Of The American Medical Association, 1999